Regenerative Treatment For An Impaired Kidney Restoration
An event that hasn’t happened before was demonstrated by researchers from Duke-NUS Medical School, colleagues...
Fatty Liver Disease Gets A Novel Drug Healing Contender
Karolinska Institute researchers have come up with a promising antibody medication candidate for the medication...
Singapore Witnesses A $50mn Funding In Research & Innovation
NUS Academic Medical Centre and SingHealth in Singapore have announced a gift of $50 million,...
Novel Research Says Actin A Key Source of Spreading Cancer
The University of Freiburg researchers have found out that the release of prometastatic factors is...
Genomic Ties Announced By UK With Thailand On Health Issues
A new partnership with Thailand to share the expertise of genome sequencing, research collaboration, education...
South Korean Pharma Sector Attracts Despite Drug Nod Delays
According to a survey from Fitch Solutions, South Korea's pharmaceutical market attractiveness is expected to...
To Curb Medicine Inequality, 3-Year Novel Strategy Announced
A novel strategy for 2023–25 adopted by the Medicines Patent Pool looks to lessen the...
EC approves Regeneron-Sanofi’s Dupixent for eosinophilic esophagitis
The European Commission (EC) has granted marketing authorisation for Regeneron Pharmaceuticals and Sanofi’s Dupixent (dupilumab)...
Seqens Group Opens Flagship Pharmaceutical R&D Center in Greater Boston
Seqens Group opens the Seqens Boston R&D Center, a state-of-the-art, 15,000 square-foot R&D center in...
Moderna Granted FDA Breakthrough Therapy Designation for mRNA-1345, An Investigational Respiratory Syncytial Virus Vaccine...
Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, announced mRNA-1345, an investigational...